Endocrinology, Vol 113, 2043-2051, Copyright © 1983 by Endocrine Society

ARTICLES

Characterization of rat brain aldosterone receptors reveals high affinity for corticosterone

K Beaumont and DD Fanestil

The two [3H]aldosterone-binding proteins of rat brain cytosol were characterized by a dextran-coated charcoal method. With molybdate present to stabilize receptors, the affinities of the two sites for [3H]aldosterone in adrenalectomized perfused rat brain cytosols were 0.28 and 18.0 nM at 4 C. High affinity sites comprised 15% of the total receptor number. A small contamination of perfused brain cytosol preparations with corticosteroid-binding globulin (CBG) was found. However, due to the very high affinity of CBG for corticosterone at 4 C, this slight contamination resulted in significant alterations in the apparent affinity of steroids competing for aldosterone-binding sites. Selective precipitation of cytosol receptors with 36% (NH4)2SO4 reduced CBG concentrations to negligible levels. After blockade of low affinity sites with a highly selective glucocorticoid (RU 26988), the order of steroids in competing for the high affinity receptor was desoxycorticosterone greater than fludrocortisone greater than corticosterone greater than aldosterone greater than progesterone greater than dexamethasone. Readdition of a small quantity of dialyzed serum to cytosol preparations yielded a profile of steroid binding similar to that of the kidney mineralocorticoid receptor (aldosterone greater than desoxycorticosterone greater than corticosterone). The distribution of both receptors in brain regions of adrenalectomized rats was determined. Both receptors were at greatest density in the hippocampus and lowest density in the hypothalamus. The high affinity site was at greatest density in limbic regions, whereas the low affinity receptor, apparently identical to the glucocorticoid type II receptor, was at greatest density in cortex and cerebellum. It is concluded that the high affinity aldosterone receptor of rat brain, which had been identified in preliminary studies as a mineralocorticoid receptor, may bind either corticosterone or aldosterone in vivo.

This article has been cited by other articles:

				M. E. Baker Evolution of Glucocorticoid and Mineralocorticoid Responses: Go Fish Endocrinology, October 1, 2003; 144(10): 4223 - 4225. [Full Text] [PDF]

				R. M. LOSEL, E. FALKENSTEIN, M. FEURING, A. SCHULTZ, H.-C. TILLMANN, K. ROSSOL-HASEROTH, and M. WEHLING Nongenomic Steroid Action: Controversies, Questions, and Answers Physiol Rev, July 1, 2003; 83(3): 965 - 1016. [Abstract] [Full Text] [PDF]

				A. T. Stauffer, M. K. Rochat, B. Dick, F. J. Frey, and A. Odermatt Chenodeoxycholic Acid and Deoxycholic Acid Inhibit 11beta -Hydroxysteroid Dehydrogenase Type 2 and Cause Cortisol-induced Transcriptional Activation of the Mineralocorticoid Receptor J. Biol. Chem., July 12, 2002; 277(29): 26286 - 26292. [Abstract] [Full Text] [PDF]

				M. Nishi, H. Ogawa, T. Ito, K.-I. Matsuda, and M. Kawata Dynamic Changes in Subcellular Localization of Mineralocorticoid Receptor in Living Cells: In Comparison with Glucocorticoid Receptor using Dual-Color Labeling with Green Fluorescent Protein Spectral Variants Mol. Endocrinol., July 1, 2001; 15(7): 1077 - 1092. [Abstract] [Full Text] [PDF]

				N. B. Hastings, M. Orchinik, M. V. Aubourg, and B. S. McEwen Pharmacological Characterization of Central and Peripheral Type I and Type II Adrenal Steroid Receptors in the Prairie Vole, a Glucocorticoid-Resistant Rodent Endocrinology, October 1, 1999; 140(10): 4459 - 4469. [Abstract] [Full Text]

				A. Odermatt, P. Arnold, A. Stauffer, B. M. Frey, and F. J. Frey The N-terminal Anchor Sequences of 11beta -Hydroxysteroid Dehydrogenases Determine Their Orientation in the Endoplasmic Reticulum Membrane J. Biol. Chem., October 1, 1999; 274(40): 28762 - 28770. [Abstract] [Full Text] [PDF]

				M. F. Roitman, T. A. Patterson, R. R. Sakai, I. L. Bernstein, and D. P. Figlewicz Sodium depletion and aldosterone decrease dopamine transporter activity in nucleus accumbens but not striatum Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1999; 276(5): R1339 - R1345. [Abstract] [Full Text] [PDF]

				P. C. White, T. Mune, and A. K. Agarwal 11{beta}-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess Endocr. Rev., February 1, 1997; 18(1): 135 - 156. [Abstract] [Full Text]

				J. Funder, P. Pearce, R Smith, and A. Smith Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated Science, October 28, 1988; 242(4878): 583 - 585. [Abstract] [PDF]

				J. Funder Adrenal steroids: new answers, new questions Science, July 17, 1987; 237(4812): 236 - 237. [PDF]

				J. Arriza, C Weinberger, G Cerelli, T. Glaser, B. Handelin, D. Housman, and R. Evans Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor Science, July 17, 1987; 237(4812): 268 - 275. [Abstract] [PDF]

				A. Odermatt, P. Arnold, and F. J. Frey The Intracellular Localization of the Mineralocorticoid Receptor Is Regulated by 11beta -Hydroxysteroid Dehydrogenase Type 2 J. Biol. Chem., July 20, 2001; 276(30): 28484 - 28492. [Abstract] [Full Text] [PDF]